Skip to content

Effect of sharapunkha lepa application in Sadyovrana

An open label single arm clinical study to evaluate the Sharapunkha lepa in the management of Sadyovrana. - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/089951
Enrollment
30
Registered
2025-07-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

None listed

Sponsors

Dr Ashok Kumar S
Lead Sponsor
Dr Dharmapal S L
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Subjects irrespective of age, sex and occupation. Sadyovrana upto deep fascia.

Exclusion criteria

Exclusion criteria: Sadyovrana with injury to major blood vessels, nerves or vital organs. Sadyovrana breaching deep fascia. Wound associated with Fracture. Wound that require suture. The subjects having Sadyovrana with complications like Marmaghata. Medico-legal cases. Subjects suffering from complicated systemic disorders that which interfere in the line of treatment. Subjects of known cases like Malignancy, Gangrene, Leprosy, TB wound, HIV, Hepatitis-B.

Design outcomes

Primary

MeasureTime frame
Fast healing of woundTimepoint: 10 days

Secondary

MeasureTime frame
Quick Healthy granulation tissue formationTimepoint: 10 days

Countries

India

Contacts

Public ContactDr Ashok Kumar S

Ashwini Ayurvedic Medical College and Research centre

drdharmapal@gmail.com9916121607

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026